Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data
Abstract Background While many new medications may offer advantages over existing drugs, some newer drugs are reformulations of existing products that provide little innovation or incremental benefit while driving up drug costs. Despite the lack of benefit of these medications, prescribers may be mo...
Main Authors: | Manvi Sharma, Aisha Vadhariya, Michael L. Johnson, Zachary A. Marcum, Holly M. Holmes |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12913-018-3043-8 |
Similar Items
-
Impact of US industry payment disclosure laws on payments to surgeons: a natural experiment
by: Taeho Greg Rhee, et al.
Published: (2020-01-01) -
Searchable databse for physician CMS payments
by: Robbins RA
Published: (2014-04-01) -
Macra: the next iteration in physician payments and its impact on the state Of Iowa
by: Nelson, David Thomas
Published: (2017) -
Heterogeneous Responses in Prescriptions to Medicare Part D: A Case Study on Physician Decision-Making and Antibiotics
by: Chiang, Tsun-Kang Trent
Published: (2015) -
Towards Patient-Centered Conflicts of Interest Policy
by: Peter D. Young, et al.
Published: (2018-02-01)